메뉴 건너뛰기




Volumn 20, Issue 6, 2014, Pages 580-585

Improvement in the outcome of invasive fusariosis in the last decade

(34)  Nucci, M a   Marr, K A b   Vehreschild, M J G T c   de Souza, C A d   Velasco, E e   Cappellano, P f   Carlesse, F f   Queiroz Telles, F g   Sheppard, D C h   Kindo, A i   Cesaro, S j   Hamerschlak, N k   Solza, C l   Heinz, W J m   Schaller, M n   Atalla, A o   Arikan Akdagli, S p   Bertz, H q   Galvao Castro C k   Herbrecht, R r   more..


Author keywords

Epidemiology; Fusariosis; Outcome; Treatment; Voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CORTICOSTEROID; LIPID; POSACONAZOLE; TERBINAFINE; VORICONAZOLE; AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN B, DEOXYCHOLATE DRUG COMBINATION; ANTIFUNGAL AGENT; DEOXYCHOLIC ACID; DRUG COMBINATION;

EID: 84904434174     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12409     Document Type: Article
Times cited : (162)

References (13)
  • 1
    • 35448960891 scopus 로고    scopus 로고
    • Fusarium infections in immunocompromised patients
    • Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20: 695-704.
    • (2007) Clin Microbiol Rev , vol.20 , pp. 695-704
    • Nucci, M.1    Anaissie, E.2
  • 2
    • 0038345403 scopus 로고    scopus 로고
    • Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
    • Nucci M, Anaissie EJ, Queiroz-Telles F et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98: 315-319.
    • (2003) Cancer , vol.98 , pp. 315-319
    • Nucci, M.1    Anaissie, E.J.2    Queiroz-Telles, F.3
  • 3
    • 2342455726 scopus 로고    scopus 로고
    • Fusarium infection in hematopoietic stem cell transplant recipients
    • Nucci M, Marr KA, Queiroz-Telles F et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38: 1237-1242.
    • (2004) Clin Infect Dis , vol.38 , pp. 1237-1242
    • Nucci, M.1    Marr, K.A.2    Queiroz-Telles, F.3
  • 4
    • 38049153781 scopus 로고    scopus 로고
    • Update on the treatment of disseminated fusariosis: focus on voriconazole
    • Stanzani M, Tumietto F, Vianelli N, Baccarani M. Update on the treatment of disseminated fusariosis: focus on voriconazole. Ther Clin Risk Manag 2007; 3: 1165-1173.
    • (2007) Ther Clin Risk Manag , vol.3 , pp. 1165-1173
    • Stanzani, M.1    Tumietto, F.2    Vianelli, N.3    Baccarani, M.4
  • 5
    • 77957334912 scopus 로고    scopus 로고
    • International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole
    • Lortholary O, Obenga G, Biswas P et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 2010; 54: 4446-4450.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 4446-4450
    • Lortholary, O.1    Obenga, G.2    Biswas, P.3
  • 6
    • 46249126149 scopus 로고    scopus 로고
    • Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
    • de Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
    • (2008) Clin Infect Dis , vol.46 , pp. 1813-1821
    • de Pauw, B.1    Walsh, T.J.2    Donnelly, J.P.3
  • 8
    • 84862889055 scopus 로고    scopus 로고
    • Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology
    • Debourgogne A, de Hoog S, Lozniewski A, Machouart M. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology. Eur J Clin Microbiol Infect Dis 2012; 31: 615-618.
    • (2012) Eur J Clin Microbiol Infect Dis , vol.31 , pp. 615-618
    • Debourgogne, A.1    de Hoog, S.2    Lozniewski, A.3    Machouart, M.4
  • 9
    • 46249130819 scopus 로고    scopus 로고
    • Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy
    • Tortorano AM, Prigitano A, Dho G et al. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother 2008; 52: 2683-2685.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2683-2685
    • Tortorano, A.M.1    Prigitano, A.2    Dho, G.3
  • 11
    • 85030409627 scopus 로고    scopus 로고
    • Treatment and prevention of Fusarium infection
    • In: Rose BD, ed Waltham, MA: UpToDate
    • Nucci M, Anaissie E. Treatment and prevention of Fusarium infection. In: Rose BD, ed. UpToDate. Waltham, MA: UpToDate, 2012.
    • (2012) UpToDate
    • Nucci, M.1    Anaissie, E.2
  • 12
    • 84866165812 scopus 로고    scopus 로고
    • Improved outcome in pediatric AML due to augmented supportive care
    • Jastaniah W, Abrar MB, Khattab TM. Improved outcome in pediatric AML due to augmented supportive care. Pediatr Blood Cancer 2012; 59: 919-921.
    • (2012) Pediatr Blood Cancer , vol.59 , pp. 919-921
    • Jastaniah, W.1    Abrar, M.B.2    Khattab, T.M.3
  • 13
    • 54049126614 scopus 로고    scopus 로고
    • Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
    • Kantarjian H, O'Brien S, Cortes J et al. Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years. Cancer 2008; 113: 1933-1952.
    • (2008) Cancer , vol.113 , pp. 1933-1952
    • Kantarjian, H.1    O'Brien, S.2    Cortes, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.